Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News on Pharma

AstraZeneca falls to third-largest UK company amid US merger talks

Proposed $400bn tie-up with Bristol Myers Squibb would create world’s fourth-largest drugmaker but analysts question rationale

The Guardian - UK

Despite Trump's backing, Vivek Ramaswamy can't curry favor with MAGA bros in Ohio

The TOI correspondent from Washington : Every Indian child grows up hearing at least two pieces of parental advice: study hard, and don't talk back. Vivek Ramaswamy followed the first well enough to become a biotech billionaire before he turned forty. But talking down at a tetchy MAGA townhall on…

The Times of India

One in Three U.S. Communities Has No Preferred Medicare Pharmacy, and That Gap Changes What Seniors Pay

One in three U.S. ZIP code areas lacks a preferred Medicare pharmacy, a new study finds. Here is how that gap changes what seniors pay.

Medical Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Public Comment Closes on the FDA Plan to Permanently Bar Bulk Compounding of Semaglutide and Tirzepatide

The comment window on FDA's proposal to keep semaglutide and tirzepatide off the 503B bulk list closed July 30. No final decision has been announced.

Medical Daily

Active U.S. Drug Shortages Have Risen to 223, and Two Official Counts Disagree on the Scale

Pharmacists count 223 active US drug shortages while the FDA tracks far fewer. Here is why the two numbers differ and what it means for patients.

Medical Daily

Judge Says the FDA Never Explained Why Mifepristone Prescriber Certification Was Necessary

A federal judge ruled the FDA failed to justify its 2023 mifepristone REMS requirements. The rules stay in effect while the agency reconsiders.

Medical Daily

Medicare to End Premium Stabilization Program for Standalone Drug Plans

CMS is ending the Part D Premium Stabilization Demonstration after 2026. Here is what it did and what seniors will learn in September.

Medical Daily

Read news from The Economist, FT, and more,
with one subscription

Trump Administration Pulls the Plug on a Medicare Subsidy That Cut Drug Premiums— Oz Says the 'Bailout' Is Over as Seniors Brace for 2027 Hikes

The Centers for Medicare & Medicaid Services (CMS) announced Tuesday it will end the Medicare Part D Premium Stabilization Demonstration after the 2026 plan year, ending a federal subsidy program that has helped keep prescription drug premiums lower and could result in higher costs for some seniors beginning in 2027.

Benzinga

GSK heads to Cambridge with long-awaited positive vibes

Pharmaceutical company’s move to new £400m research centre accompanied by encouraging news for shareholders

The Guardian - UK

If Your Weight Loss Injection Comes From a Compounder, Here Is What to Ask Before the Next Refill

Compounded GLP-1 users face a July 30 FDA comment deadline. Here is how to tell what you are taking and what to ask your pharmacy.

Medical Daily

GSK to cut jobs amid £1.9bn cost-cutting plan and bid for faster drug development

Pharmaceuticals company is investing £400m in UK life sciences and moving scientists to new Cambridge R&D site

The Guardian - UK

ADHD And Chronic Pain Patients May Struggle To Fill Prescriptions As Controlled Substance Shortages Persist Nationwide

ASHP says 16% of active drug shortages are controlled substances. Here is how partial fills and prescription transfers work at the pharmacy counter.

Medical Daily

Denied Coverage For Wegovy Or Zepbound? Here Is What The Latest Value Assessment Says About Price And Access

Denied for Wegovy or Zepbound? A new value analysis explains why plans refuse coverage and what exceptions and appeals actually involve.

Medical Daily

Trump's Tariffs Are Targeting Indian Drugmakers. Americans Could Soon Pay More for Generic Medicines, CEO Warns

Erez Israeli, CEO of Dr. Reddy's Laboratories, said that President Donald Trump's proposed tariffs on imported generic medicines would inevitably translate into higher prices for patients.

International Business Times

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

AstraZeneca boss urges western drugmakers to move at ‘Chinese speed’

Europe and US risk being outpaced on innovation, as happened in the car industry, warns Pascal Soriot

Medical Daily

DEA Could Ban Concentrated 7-OH Kratom Products Any Time After August 5 — What Consumers Need to Know

DEA's temporary Schedule I order for concentrated 7-OH kratom products can issue any time after August 5. What the threshold covers and who is affected.

Benzinga

Two Years to Build or Pay 200% — Which US Pharma Stocks Win?

President Donald Trump has given generic-drug manufacturers a choice – add U.S. capacity within two years or face tariffs.

International Business Times

Pfizer and the $200 Billion-Dollar Cardiovascular Market

Pfizer's cardiovascular business highlights the intersection of drug pricing, marketing, patents, and competition in the rapidly growing $200 billion heart disease market.

Get all your
news in one place.

100's of premium titles.
One news app.

Bangkok Post

US panel says to loosen restrictions on popular peptide despite safety concerns

NEW YORK - A US review panel on Thursday recommended loosening restrictions on the much hyped peptide BPC-157, voting that specialized pharmacies be allowed to produce it despite alarm bells from medical experts over safety concerns.

The Independent UK

FDA reviews peptide injections favored by RFK Jr. and wellness influencers

Federal health advisers are meeting to review a group of controversial chemicals called peptides

Medical Daily

U.S. Drug Shortages Climb to 227 Medications as CT Contrast Agents and Chemotherapy Drugs Remain Critically Scarce

U.S. drug shortages rose to 227 in Q2 2026, marking a third straight quarterly increase. CT contrast agents and the cancer drug ifosfamide are critically scarce. Here's what patients need to know.

The Independent UK

Two weight-loss drugmakers in legal battle over which is most effective in helping users shed pounds

Novo Nordisk claims Eli Lilly compared peak doses of Zepbound against outdated, lower doses of Wegovy to advertise a 50-pound weight loss versus 33 pounds

The Guardian - AU

At-home STI test pulled from Australian shelves after failing to detect infections

Exclusive: TGA finds Touch Biotechnology test for chlamydia and gonorrhoea ‘is not reliable’ and has affected an unspecified number of people

International Business Times UK

TrumpRx Explained: Why the Drug Discount Site Was 'Never Meant' for Insured Americans as Only 7% Visited It

A senior HHS official says TrumpRx was never meant for insured Americans, as KFF polling shows just 7% of prescription drug users have visited the discount site.

The Independent UK

FDA approves a first-of-its-kind pill to cut cholesterol in high-risk patients

The Food and Drug Administration has approved a first-of-its-kind pill that can drastically reduce cholesterol

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

353 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.